d-Testosterone

About Lennham Pharmaceuticals

Lennham Pharmaceuticals is a private, pre-clinical stage biotech utilizing deuterium substitution as its core technology platform to enhance drug properties. Its pipeline includes deuterated versions of caffeine, psilocybin, and testosterone, targeting inflammatory and autoimmune conditions with the goal of achieving better safety and efficacy profiles. The company emphasizes strong intellectual property generation and advancing programs with high clinical and commercial potential. As a pre-revenue entity, it operates with a focused team of industry experts in the competitive Boston-Cambridge biotech hub.

Therapeutic Areas

Other Not Specified (Inflammatory/Autoimmune Focus) Drugs